APP下载

卡培他滨联合放疗与单纯放疗治疗消化道恶性肿瘤的临床效果及可行性分析

2019-10-02江涛何苗青亮程宏文

中国医学创新 2019年22期

江涛 何苗 青亮 程宏文

【摘要】 目的:探討分析卡培他滨联合放疗与单纯放疗方式治疗消化道恶性肿瘤的临床效果与可行性。方法:选取本院2015年5月-2016年5月收治的消化道恶性肿瘤患者60例作为研究对象

,按照随机数字表法将其分为对照组(n=30)和研究组(n=30)。对照组单纯给予放疗治疗,研究组则给予卡培他滨联合放疗方式治疗,比较两组治疗后的临床效果、生存及不良反应发生情况。结果:研究组治疗后的总有效率、疾病控制情况及2年生存率均明显高于对照组,差异均有统计学意义(字2=11.169、10.219、15.352,P<0.05)。研究组疾病进展时间及治疗后的不良反应发生率均明显低于对照组,差异均有统计学意义(字2=12.222、13.363,P=0.000)。两组治疗后的1年生存率比较,差异无统计学意义(字2=2.116,P=0.146)。结论:对消化道恶性肿瘤患者在临床治疗中给予卡培他滨联合放疗,能有效提高临床治疗效果,减少不良反应发生,改善患者生存质量,可广泛用于临床中。

【关键词】 消化道恶性肿瘤; 卡培他滨; 放疗

Analysis of Clinical Effect and Feasibility of Capecitabine Combined with Radiotherapy and Radiotherapy alone in the Treatment of Malignant Tumors of Digestive Tract/JIANG Tao,HE Miao,QING Liang,et al.//Medical Innovation of China,2019,16(22):-168

【Abstract】 Objective:To probe into and analyze the clinical effect and feasibility of Capecitabine combined with radiotherapy and radiotherapy alone in the treatment of malignant tumors of digestive tract.Method:A total of 60 patients with malignant tumors of digestive tract treated in our hospital from May 2015 to May 2016 were selected as research objects.According to the random number table method,they were divided into the control group(n=30)and the study group(n=30).The control group was treated with radiotherapy alone,the study group was treated with Capecitabine combined with radiotherapy.The clinical effect,survival and adverse reactions between the two groups were compared.Result:The total effective rate,disease control and 2-year survival rate of the study group after treatment were significantly higher than those of the control group,the differences were statistically significant(字2=11.169,10.219,15.352,P<0.05).The time of disease progression and the incidence of adverse reactions after treatment in the study group were significantly lower than those in the control group,the differences were statistically significant(字2=12.222,13.363,P=0.000).There was no significant difference in 1-year survival rate between the two groups(字2=2.116,P=0.146).Conclusion:Capecitabine combined with radiotherapy in the clinical treatment of patients with digestive tract malignant tumors can effectively improve the clinical treatment effect,reduce the occurrence of adverse reactions and improve the quality of life of patients,thus it can be widely used in clinical.

【Key words】 Malignant tumors of digestive tract; Capecitabine; Radiotherapy

First-authors address:Chongqing Wanzhou District Peoples Hospital,Chongqing 404100,China

doi:10.3969/j.issn.1674-4985.2019.22.043

消化道恶性肿瘤是临床中常见的一种消化道病症,它是指发生在人体消化系统的肿瘤,常见的主要有食管癌、直肠癌或胃癌等[1],有着较高的发病率与死亡率;消化道肿瘤在发病早期通常无明显症状,多数患者为体检时偶然发现,且多数患者在确诊时其局部病灶已经发生转移或广泛浸润,使得患者失去了临床最佳治疗时机,在对其治疗中已经无法采用根治性手术。因此对于消化道恶心肿瘤患者通常多采用放疗治疗方式,作为一种全身性治疗方式,是临床中治疗晚期消化道肿瘤的首选治疗方式。但单纯对患者行放疗治疗,其临床效果不显著,无法有效提高患者远期生存率,因而在对其治疗中多联合抗肿瘤药物以提高治疗效果。因此在本次的研究分析中,将对卡培他滨联合放疗与单纯放疗方式治疗消化道恶性肿瘤的临床效果与可行性展开更进一步的探讨,现报道如下。……

登录APP查看全文